News

ARDELYX ($ARDX) posted quarterly earnings results on Thursday, May 1st. The company reported earnings of -$0.17 per share, missing estimates of -$0.12 by $0.05. The company also reported revenue of $74,110,000, missing estimates of $80,380,284 by $-6,270,284.

You can see Quiver Quantitative's $ARDX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

ARDELYX Insider Trading Activity

ARDELYX insiders have traded $ARDX stock on the open market 24 times in the past 6 months. Of those trades, 4 have been purchases and 20 have been sales.

Here’s a breakdown of recent trading of $ARDX stock by insiders over the last 6 months:

• DAVID M MOTT has made 4 purchases buying 705,897 shares for an estimated $3,374,588 and 0 sales.
• MICHAEL RAAB (President & CEO) has made 0 purchases and 9 sales selling 274,353 shares for an estimated $1,421,009.
• DAVID P. ROSENBAUM (Chief Development Officer) has made 0 purchases and 4 sales selling 61,527 shares for an estimated $361,860.
• LAURA A WILLIAMS (Chief Medical Officer) has made 0 purchases and 2 sales selling 12,307 shares for an estimated $63,099.
• ELIZABETH A GRAMMER (See Remarks) has made 0 purchases and 2 sales selling 11,337 shares for an estimated $57,910.
• JUSTIN A RENZ (Chief Financial Officer) has made 0 purchases and 2 sales selling 10,431 shares for an estimated $54,295.
• ROBERT BLANKS (See Remarks) sold 4,941 shares for an estimated $23,689

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ARDELYX Hedge Fund Activity

We have seen 116 institutional investors add shares of ARDELYX stock to their portfolio, and 96 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JANUS HENDERSON GROUP PLC added 2,858,061 shares (+13.3%) to their portfolio in Q4 2024, for an estimated $14,490,369
• TWO SEAS CAPITAL LP added 1,855,337 shares (+inf%) to their portfolio in Q4 2024, for an estimated $9,406,558
• EVENTIDE ASSET MANAGEMENT, LLC removed 1,812,285 shares (-24.4%) from their portfolio in Q4 2024, for an estimated $9,188,284
• ROCK SPRINGS CAPITAL MANAGEMENT LP added 1,463,629 shares (+inf%) to their portfolio in Q4 2024, for an estimated $7,420,599
• D. E. SHAW & CO., INC. added 1,453,369 shares (+9499.8%) to their portfolio in Q4 2024, for an estimated $7,368,580
• MACQUARIE GROUP LTD added 1,398,144 shares (+15.6%) to their portfolio in Q4 2024, for an estimated $7,088,590
• RUBRIC CAPITAL MANAGEMENT LP removed 1,353,706 shares (-44.2%) from their portfolio in Q4 2024, for an estimated $6,863,289

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ARDELYX Government Contracts

We have seen $40,332 of award payments to $ARDX over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• XPHOZAH: $34,284
• XPHOZAH 30MG TABS: $6,048

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

ARDELYX Analyst Ratings

Wall Street analysts have issued reports on $ARDX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Scotiabank issued a "Outperform" rating on 03/07/2025
• BTIG issued a "Buy" rating on 03/04/2025
• Jefferies issued a "Buy" rating on 01/02/2025

To track analyst ratings and price targets for ARDELYX, check out Quiver Quantitative's $ARDX forecast page.

ARDELYX Price Targets

Multiple analysts have issued price targets for $ARDX recently. We have seen 2 analysts offer price targets for $ARDX in the last 6 months, with a median target of $11.0.

Here are some recent targets:

• An analyst from BTIG set a target price of $14.0 on 03/04/2025
• Dennis Ding from Jefferies set a target price of $8.0 on 01/02/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

This article was originally published on Quiver News, read the full story.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.